Vittoria Borgonetti
Overview
Explore the profile of Vittoria Borgonetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borgonetti V, Governa P, Morozzi M, Sasia C, Videtta G, Biagi M, et al.
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002693
: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by demyelination and neuronal damage. Current MS therapies are unsatisfactory, and new therapies are encouraged....
2.
Sasia C, Borgonetti V, Mancini C, Lori G, Arbiser J, Taddei M, et al.
Cells
. 2024 Oct;
13(19.
PMID: 39404415
Microglia-mediated neuroinflammation has been linked to neurodegenerative disorders. Inflammation and aging contribute to microglial senescence. Microglial senescence promotes the development of neurodegenerative disorders, including Alzheimer's disease (AD). In this study,...
3.
Borgonetti V, Vozella V, Ware T, Cruz B, Bullard R, Cravatt B, et al.
Pharmacol Res
. 2024 Oct;
209:107462.
PMID: 39396766
Epidemiological data indicate a strong association between alcohol use disorder (AUD) and neuropathic pain. Genetically-selected Marchigian Sardinian alcohol-preferring (msP) rats exhibit a high preference for alcohol compared with their background...
4.
Borgonetti V, Morozzi M, Galeotti N
Neuropharmacology
. 2024 Aug;
259:110120.
PMID: 39159835
A large portion of neuropathic pain suffering patients may also concurrently experience neuropathic itch, with a negative impact on the quality of life. The limited understanding of neuropathic itch and...
5.
Patel R, Gandhi P, Spencer K, Salem N, Erikson C, Borgonetti V, et al.
Neurobiol Stress
. 2024 Jul;
31:100657.
PMID: 38983690
Chronic ethanol dependence and withdrawal activate corticotropin releasing factor (CRF)-containing GABAergic neurons in the medial prefrontal cortex (mPFC), which tightly regulate glutamatergic pyramidal neurons. Using male CRF1:GFP reporter mice, we...
6.
Cruz B, Vozella V, Borgonetti V, Bullard R, Bianchi P, Kirson D, et al.
Mol Psychiatry
. 2024 Mar;
29(9):2611-2621.
PMID: 38509197
Post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) are often comorbid. Few treatments exist to reduce comorbid PTSD/AUD. Elucidating the mechanisms underlying their comorbidity could reveal new avenues for...
7.
Mugnaini C, Brizzi A, Paolino M, Scarselli E, Castelli R, De Candia M, et al.
ACS Chem Neurosci
. 2024 Feb;
15(5):955-971.
PMID: 38372253
Alzheimer's disease (AD) is a neurodegenerative form of dementia characterized by the loss of synapses and a progressive decline in cognitive abilities. Among current treatments for AD, acetylcholinesterase (AChE) inhibitors...
8.
Borgonetti V, Galeotti N
Int J Mol Sci
. 2023 Sep;
24(18).
PMID: 37762339
Memory deficit is one of the major negative outcomes of chronic stress. Cholinergic system modulates memory not only through the neuronal cells, but also via interactions with non-neuronal cells, suggesting...
9.
Borgonetti V, Galeotti N
Antioxidants (Basel)
. 2023 Aug;
12(8).
PMID: 37627513
Neuropathic pain (NP) affects about 8% of the general population. Current analgesic therapies have limited efficacy, making NP one of the most difficult to treat pain conditions. Evidence indicates that...
10.
Cruz B, Borgonetti V, Bajo M, Roberto M
Neurobiol Stress
. 2023 Aug;
26:100562.
PMID: 37601537
Excessive alcohol use disrupts neuroimmune signaling across various cell types, including neurons, microglia, and astrocytes. The present review focuses on recent, albeit limited, evidence of sex differences in biological factors...